Blog
RSS FeedPosted by Michael Wonder on 26 Oct 2016
Update to CADTH Guidelines for the Economic Evaluation of Health Technologies
27 October 2016 - CADTH's current Guidelines for the Economic Evaluation of Health Technologies (3rd edition) were published in ...
Posted by Michael Wonder on 20 Oct 2016
Ottawa’s gloves come off over health-care funding
19 October 2016 - It’s been a while since Canadians have heard their Prime Minister berate the provinces for how ...
Posted by Michael Wonder on 18 Oct 2016
Ottawa won’t boost provincial health transfers without reform plan: Philpott
16 October 2016 - The federal Health Minister says Ottawa has been giving large sums of money to the provinces ...
Posted by Michael Wonder on 12 Oct 2016
CADTH calls for patient input on submission from Servier for Corlovan
11 October - CADTH is calling for patient input on a submission from Servier for Corlovan (ivabradine hydrochloride). ...
Posted by Michael Wonder on 11 Oct 2016
Cutting through the numbers on health-care funding
11 October 2016 - One of the truisms of Canadian political discourse is that the federal government grossly underfunds health ...
Posted by Michael Wonder on 07 Oct 2016
CADTH calls for patient input on a submission from Celopharma for Mifegymiso
6 October 2016 - CADTH is calling for patient input on a submission from Celopharma for its combination product Mifegymiso. ...
Posted by Michael Wonder on 04 Oct 2016
Abortion-drug company open to restarting reimbursement review process
27 September 2016 - The company that is bringing the gold standard in abortion drugs to Canada says it is “open” ...
Posted by Michael Wonder on 01 Oct 2016
CADTH publishes initial recommendation for Afinitor (everolimus)
29 September 2016 - CADTH has published its initial recommendtation for Novartis' Afinitor. ...
Posted by Michael Wonder on 27 Sep 2016
Why is getting the abortion pill to women such a complicated thing?
27 September 2016 - Already the victims of Health Canada’s glacial bureaucracy, and of its paternalistic view of their ability to ...
Posted by Michael Wonder on 26 Sep 2016
Most provincial drug plans won’t cover abortion pills in Canada
26 September 2016 - When the gold standard in medical abortion drugs finally becomes available in Canada later this year, the ...
Posted by Michael Wonder on 24 Sep 2016
CADTH publishes final recommendation for Lenvima (lenvatinib mesylate)
20 September 2016 - CADTH has posted its final outcome for Eisai's Lenvima. ...
Posted by Michael Wonder on 22 Sep 2016
CADTH calls for patient input on a resubmission from NovoNordisk for Victoza (liraglutide)
21 September 2016 - CADTH is calling for patient input on a resubmission from Novo Nordisk for Victoza (liraglutide). ...
Posted by Michael Wonder on 16 Sep 2016
CADTH drug portfolio information sessions
16 September 2016 - The CADTH Drug Portfolio Information Sessions are an opportunity for stakeholders to receive an update on the ...
Posted by Michael Wonder on 14 Sep 2016
CADTH update for patient groups
13 September 2016 - CADTH is inviting patient group comments and feedback on the proposed revisions to the patient input template ...
Posted by Michael Wonder on 13 Sep 2016
CADTH calls for patient input on submission from Sanofi for sarilumab
13 September 2016 - CADTH is calling for patient input on Sanofi Genzyme's new interleukin 6 receptor antagonist. ...